SCD Pregnancy

Release Date:

June 28, 2024

Scope of Collection
Element Considered Final Measures in Toolkit
Pre-Implantation Genetic Diagnosis
Non-Invasive Prenatal Testing Cell-free Fetal DNA Testing for Sickle Cell Disease (Supplemental Information)
Chorionic Villus Sampling (CVS) Invasive Prenatal Testing Guidelines (Supplemental Information)
Amniocentesis Invasive Prenatal Testing Guidelines (Supplemental Information)
Acute Chest Syndrome Acute Chest Syndrome During Pregnancy
Acute Chest Syndrome - General Populations (Supplemental Information)
Transfusion Prophylactic Transfusion during Pregnancy
Transfusion Indications
Transfusion Reactions
Hydroxyurea Hydroxyurea Use during Pregnancy
Hydroxyurea Use Adherence - Prospective Studies
Thromboprophylaxis Thromboprophylaxis
Thrombosis - Catheter-related
Thrombosis - Venous
Multidisciplinary Care for SCD Multidisciplinary Care for Sickle Cell Disease Pregnancies (Supplemental Information)
Working Group Roster:

WG Members:

A. Kinga Malinowski, MD, MSc, FRCSC, Co-Chair
University of Toronto
Toronto, ON
Deva Sharma, MD, MS, Co-Chair
Vanderbilt University Medical Center
Nashville, TN
Monika Asnani, DM, PhD
The University of the West Indies
Kingston, JM
Kevin Kuo, MD, MSc, FRCPC
University of Toronto
Toronto, ON
Eugene Oteng-Ntim, DTropM, PhD, FRCOG
King's College London
London, UK
Kim Smith-Whitley, MD
Global Blood Therapeutics
Children's Hospital of Philadelphia
South San Francisco, CA

Sickle Cell Disease Panel Liaison, WG Manager and WG Supervisor:

Marian Sullivan, MS, MPH, WG Supervisor
RTI International
Research Triangle Park, NC
Thien Lam, MA, WG Manager
RTI International
Research Triangle Park, NC

Supplemental Information includes protocols that the Working Group or Expert Review Panel considered useful and highly relevant to the domain but do not meet the criteria for inclusion in the Toolkit.

Additional Information:

There is no additional information for this collection.